Category: life science
-
BIO INTERNATIONAL 2023: A Lively Life Science Gathering
On June 7, 2023, I was privileged to cover the convention of the Biotechnology Industry Organization (BIO) International Convention–my first time attending the meeting since 2018, when the 25th anniversary of the gathering was held here in Boston. The excitement was back–with 9144 companies registered to attend, many with booths, tables or pavilions–and, according to…
-
Convergence Science Transforming Biomedicine, MIT Report says
“Convergence science has advanced across many fronts, from nanotechnology to regenerative tissue,” says Nobel Laureate Phil Sharp of MIT. “But the funding allocated for convergence research in biomedical science is small and needs to be expanded. In fact, there is no federal agency with the responsibility to fund convergence in biomedical research.”
-
Bid on lunch with pharma exec; benefit Water-Aid, developing world
UK/US Life science consulting firm Alacrita launches benefit auction for lunch with pharma exec to benefit Water Aid in developing world.
-
AC Immune/Genentech to Partner on R&D for Alzheimer’s Antibody; $418M Agree’t
AC Immune has entered into a second exclusive worldwide license agreement and research collaboration with Genentech,of the Roche Group, for the research, development and commercialization of AC Immune’s anti-Tau antibodies for the potential treatment of Alzheimer’s disease and other neurodegenerative diseases. The agreement is valued at $400M.
-
Bio-IT World Review: BIG Data; BIG Promise; BIG CHALLENGES.
New Cambridge Observer’s Anita Harris on BIO-IT World 2012, describing the promise and problems presented by burgeoning of health care data.
-
Merging Art & Science: MIT Koch Institute Gallery is a Must See
On my way to a meeting at MIT, I happened to spot some stunning photos through the window of what turned out to be the Philip Alden Russell Gallery David H. Koch Institute for Integrative Cancer Research. While cancer research would not seem to be much of a draw, the gallery is well worth a…